We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Thrombolytic Science, LLC (TSI), a clinical stage vascular health company developing biotechnology products to treat thrombotic diseases such as myocardial infarction (MI, or heart attack) and stroke
Sartorius, a leading international laboratory and pharmaceutical equipment supplier, yesterday announced a partnership with EMBL, the European Molecular Biology Laboratory.